When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALBO - Albireo under pressure on elobixibat strikeout in NASH
Albireo Pharma Inc.
Thinly traded micro cap Albireo Pharma (NASDAQ:ALBO) is down 12% after hours on light volume in reaction to topline results from a Phase 2 clinical trial evaluating constipation med elobixibat for the treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
More news on: Albireo Pharma, Inc., Healthcare stocks news, Stocks on the move,